Andrea Bertotti
University of Turin(IT)
Publications by Year
Research Areas
Colorectal Cancer Treatments and Studies, Cancer Genomics and Diagnostics, HER2/EGFR in Cancer Research, Cancer Cells and Metastasis, Cancer Research and Treatments
Most-Cited Works
- → Prioritization of cancer therapeutic targets using CRISPR–Cas9 screens(2019)1,391 cited
- → MET signalling: principles and functions in development, organ regeneration and cancer(2010)1,220 cited
- → Dual-targeted therapy with trastuzumab and lapatinib in treatment-refractory, KRAS codon 12/13 wild-type, HER2-positive metastatic colorectal cancer (HERACLES): a proof-of-concept, multicentre, open-label, phase 2 trial(2016)993 cited
- → A Molecularly Annotated Platform of Patient-Derived Xenografts (“Xenopatients”) Identifies HER2 as an Effective Therapeutic Target in Cetuximab-Resistant Colorectal Cancer(2011)941 cited
- → Amplification of the MET Receptor Drives Resistance to Anti-EGFR Therapies in Colorectal Cancer(2013)658 cited
- → Interrogating open issues in cancer precision medicine with patient-derived xenografts(2017)657 cited
- → Stromal contribution to the colorectal cancer transcriptome(2015)652 cited
- → The genomic landscape of response to EGFR blockade in colorectal cancer(2015)490 cited
- → EGFR Blockade Reverts Resistance to KRASG12C Inhibition in Colorectal Cancer(2020)453 cited
- → Effective drug combinations in breast, colon and pancreatic cancer cells(2022)440 cited